Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200508426> ?p ?o ?g. }
- W4200508426 endingPage "105" @default.
- W4200508426 startingPage "89" @default.
- W4200508426 abstract "To evaluate the content validity and psychometric properties of the Activity Impairment in Migraine Diary (AIM-D).Measuring treatment effects on migraine impairment requires a psychometrically sound patient-reported outcome (PRO) measure developed consistent with U.S. Food and Drug Administration guidance.The AIM-D was created from concepts that emerged during qualitative interviews with five clinicians experienced in treating migraine and concept elicitation (CE) interviews with 40 adults with episodic migraine (EM) or chronic migraine (CM). The initial version was refined based on three waves of cognitive interviews with 38 adults with EM or CM and input from a panel of clinical and measurement experts. The AIM-D was psychometrically evaluated using data from 316 adults with EM or CM who participated in a 13-week prospective observational study. Study participants completed PRO assessments including the AIM-D and a daily headache diary. Exploratory and confirmatory factor analysis were used to determine the factor structure. The reliability, validity, and responsiveness of the AIM-D were assessed. Additional PRO measures including the Patient Global Impression - Severity (PGI-S), Migraine Specific Quality of Life Questionnaire, Version 2.1 Role Function-Restrictive domain, and Headache Impact Test were used for psychometric evaluation of the AIM-D.Based on CE interviews with adults with migraine and input from an expert panel, activity impairment was identified as the target in the preliminary conceptual framework, which had two domains: performance of daily activities (PDAs) and physical impairment (PI). Revision of the draft AIM-D through multiple rounds of cognitive interviews and expert panel meetings resulted in a content valid 11-item version. Exploratory factor analysis supported both one- and two-domain structures for the AIM-D, which were further supported by confirmatory factor analysis (factor loadings all >0.90). The AIM-D domains (PDA and PI) and total score showed high internal consistency reliability (Cronbach's alpha 0.95-0.97), acceptable test-retest reliability for weekly average scores (intraclass correlation coefficient >0.60 for participants with no change in PGI-S between baseline and week 2), and good convergent and known-groups validity. There was evidence of responsiveness based on changes in PGI-S score and monthly migraine days.The AIM-D is a content valid and psychometrically sound measure designed to evaluate activity impairment and is suitable for use in clinical trials of preventive treatments for EM or CM." @default.
- W4200508426 created "2021-12-31" @default.
- W4200508426 creator A5000448269 @default.
- W4200508426 creator A5001054264 @default.
- W4200508426 creator A5009044802 @default.
- W4200508426 creator A5022457231 @default.
- W4200508426 creator A5036025969 @default.
- W4200508426 creator A5039792370 @default.
- W4200508426 creator A5047864551 @default.
- W4200508426 creator A5050403636 @default.
- W4200508426 creator A5057290642 @default.
- W4200508426 creator A5079132033 @default.
- W4200508426 date "2021-12-28" @default.
- W4200508426 modified "2023-10-12" @default.
- W4200508426 title "Development and validation of a novel patient‐reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary" @default.
- W4200508426 cites W1968001773 @default.
- W4200508426 cites W1971940798 @default.
- W4200508426 cites W1985564128 @default.
- W4200508426 cites W1990166011 @default.
- W4200508426 cites W2002101128 @default.
- W4200508426 cites W2034092396 @default.
- W4200508426 cites W2035901223 @default.
- W4200508426 cites W204766049 @default.
- W4200508426 cites W2065369272 @default.
- W4200508426 cites W2071666535 @default.
- W4200508426 cites W2078068557 @default.
- W4200508426 cites W2086325363 @default.
- W4200508426 cites W2089165963 @default.
- W4200508426 cites W2089547724 @default.
- W4200508426 cites W2112004018 @default.
- W4200508426 cites W2119011129 @default.
- W4200508426 cites W2121724211 @default.
- W4200508426 cites W2138664283 @default.
- W4200508426 cites W2159306398 @default.
- W4200508426 cites W2164777277 @default.
- W4200508426 cites W2297767387 @default.
- W4200508426 cites W2524597629 @default.
- W4200508426 cites W2528453852 @default.
- W4200508426 cites W2750798923 @default.
- W4200508426 cites W2769823665 @default.
- W4200508426 cites W2801699593 @default.
- W4200508426 cites W2805181790 @default.
- W4200508426 cites W2885852770 @default.
- W4200508426 cites W2921665697 @default.
- W4200508426 cites W3046802458 @default.
- W4200508426 cites W3130246623 @default.
- W4200508426 cites W4200508426 @default.
- W4200508426 cites W4206489152 @default.
- W4200508426 cites W4233521664 @default.
- W4200508426 doi "https://doi.org/10.1111/head.14229" @default.
- W4200508426 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34962305" @default.
- W4200508426 hasPublicationYear "2021" @default.
- W4200508426 type Work @default.
- W4200508426 citedByCount "9" @default.
- W4200508426 countsByYear W42005084262021 @default.
- W4200508426 countsByYear W42005084262022 @default.
- W4200508426 countsByYear W42005084262023 @default.
- W4200508426 crossrefType "journal-article" @default.
- W4200508426 hasAuthorship W4200508426A5000448269 @default.
- W4200508426 hasAuthorship W4200508426A5001054264 @default.
- W4200508426 hasAuthorship W4200508426A5009044802 @default.
- W4200508426 hasAuthorship W4200508426A5022457231 @default.
- W4200508426 hasAuthorship W4200508426A5036025969 @default.
- W4200508426 hasAuthorship W4200508426A5039792370 @default.
- W4200508426 hasAuthorship W4200508426A5047864551 @default.
- W4200508426 hasAuthorship W4200508426A5050403636 @default.
- W4200508426 hasAuthorship W4200508426A5057290642 @default.
- W4200508426 hasAuthorship W4200508426A5079132033 @default.
- W4200508426 hasBestOaLocation W42005084261 @default.
- W4200508426 hasConcept C105795698 @default.
- W4200508426 hasConcept C118552586 @default.
- W4200508426 hasConcept C142724271 @default.
- W4200508426 hasConcept C15744967 @default.
- W4200508426 hasConcept C165957694 @default.
- W4200508426 hasConcept C169900460 @default.
- W4200508426 hasConcept C171606756 @default.
- W4200508426 hasConcept C1862650 @default.
- W4200508426 hasConcept C23131810 @default.
- W4200508426 hasConcept C2778541695 @default.
- W4200508426 hasConcept C2779517570 @default.
- W4200508426 hasConcept C2779951463 @default.
- W4200508426 hasConcept C2910587157 @default.
- W4200508426 hasConcept C33923547 @default.
- W4200508426 hasConcept C40722632 @default.
- W4200508426 hasConcept C542102704 @default.
- W4200508426 hasConcept C70410870 @default.
- W4200508426 hasConcept C71104824 @default.
- W4200508426 hasConcept C71924100 @default.
- W4200508426 hasConcept C79544238 @default.
- W4200508426 hasConceptScore W4200508426C105795698 @default.
- W4200508426 hasConceptScore W4200508426C118552586 @default.
- W4200508426 hasConceptScore W4200508426C142724271 @default.
- W4200508426 hasConceptScore W4200508426C15744967 @default.
- W4200508426 hasConceptScore W4200508426C165957694 @default.
- W4200508426 hasConceptScore W4200508426C169900460 @default.
- W4200508426 hasConceptScore W4200508426C171606756 @default.
- W4200508426 hasConceptScore W4200508426C1862650 @default.
- W4200508426 hasConceptScore W4200508426C23131810 @default.